Search Results - "Burmeister T"

Molecular monitoring in NUP214-ABL-positive T-acute lymphoblastic leukemia reveals clonal diversity and helps to guide targeted therapy.

Authors: Koschmieder, S Burmeister, T Brüggemann, M et al.

Source: Leukemia (08876924). Feb2014, Vol. 28 Issue 2, p419-422. 4p. 1 Color Photograph, 1 Graph.

Complex MLL rearrangements in t(4;11) leukemia patients with absent AF4·MLL fusion allele.

Authors: Kowarz, E. Burmeister, T. Lo Nigro, L. et al.

Source: Leukemia (08876924). Jun2007, Vol. 21 Issue 6, p1232-1238. 7p. 3 Diagrams.

Monitoring minimal residual disease by quantification of genomic chromosomal breakpoint sequences in acute leukemias with MLL aberrations.

Authors: Burmeister, T. Marschalek, R. Schneider, B. et al.

Source: Leukemia (08876924). Mar2006, Vol. 20 Issue 3, p451-457. 7p. 1 Diagram, 1 Chart, 2 Graphs.

Molecular heterogeneity of sporadic adult Burkitt-type leukemia/lymphoma as revealed by PCR and cytogenetics: correlation with morphology, immunology and clinical features.

Authors: Burmeister, T. Schwartz, S. Horst, H.-A. et al.

Source: Leukemia (08876924). Aug2005, Vol. 19 Issue 8, p1391-1398. 8p.

Quality assurance in RT-PCR-based BCR/ABL diagnostics--results of an interlaboratory test and a standardization approach.

Authors: Burmeister, T. Maurer, J. Aivado, M. et al.

Source: Leukemia (08876924). Oct2000, Vol. 14 Issue 10, p1850-1856. 7p.

Spliced MLL fusions: a novel mechanism to generate functional chimeric MLL-MLLT1 transcripts in t(11;19)(q23;p13.3) leukemia.

Authors: Meyer, C. Burmeister, T. Strehl, S. et al.

Source: Leukemia (08876924). Mar2007, Vol. 21 Issue 3, p588-590. 3p. 1 Diagram.

Combined automated cell and flow cytometric analysis enables recognition of persistent polyclonal B-cell lymphocytosis (PPBL), a study of 25 patients.

Authors: Schmidt-Hieber, M. Burmeister, T. Weimann, A. et al.

Source: Annals of Hematology. Oct2008, Vol. 87 Issue 10, p829-836. 8p. 1 Color Photograph, 1 Diagram, 2 Charts, 1 Graph.

The MLL recombinome of acute leukemias in 2013.

Authors: Meyer, C Hofmann, J Burmeister, T et al.

Source: Leukemia (08876924). Nov2013, Vol. 27 Issue 11, p2165-2176. 12p.

Pharmacogenetic Testing for DPD Deficiency.

Authors: Pretzsch, T. Schwab, M. Blau, O. et al.

Source: Deutsches Ärzteblatt International. 8/8/2025, Vol. 122 Issue 16, p5-5. 1p.

Novel activating STAT5B mutations as putative drivers of T-cell acute lymphoblastic leukemia.

Authors: Kontro, M Kuusanmäki, H Eldfors, S et al.

Source: Leukemia (08876924). Aug2014, Vol. 28 Issue 8, p1738-1742. 5p.

Randomized comparison of prophylactic and minimal residual disease-triggered imatinib after allogeneic stem cell transplantation for BCR-ABL1-positive acute lymphoblastic leukemia.

Authors: Pfeifer, H Wassmann, B Bethge, W et al.

Source: Leukemia (08876924). Jun2013, Vol. 27 Issue 6, p1254-1262. 9p. 6 Charts, 3 Graphs.

Thymic adult T-cell acute lymphoblastic leukemia stratified in standard- and high-risk group by aberrant HOX11L2 expression: experience of the German multicenter ALL study group.

Authors: Baak, U. Gökbuget, N. Orawa, H. et al.

Source: Leukemia (08876924). Jun2008, Vol. 22 Issue 6, p1154-1160. 7p. 3 Charts, 3 Graphs.

Expression of the human homologue of rat NG2 in adult acute lymphoblastic leukemia: close association with MLL rearrangement and a CD10(-)/CD24(-)/CD65s(+)/CD15(+) B-cell phenotype.

Authors: Schwartz, S Rieder, H Schläger, B et al.

Source: Leukemia (08876924). Aug2003, Vol. 17 Issue 8, p1589-1595. 7p.

612 - Idelalisib sensitivity and mechanisms of disease progression in relapsed TCF3-PBX1 acute lymphoblastic leukemia.

Authors: Eldfors, S. Kuusanmäki, H. Kontro, M. et al.

Source: European Journal of Cancer. Jul2016 Supplement 1, Vol. 61, pS136-S136. 1p.

Efficacy of imatinib maintenance after stem cell transplantation for Ph+/BCR::ABL1 positive ALL: long-term outcome of a randomized trial and impact of peritransplant minimal residual disease.

Authors: Pfeifer H Bethge W Schönland S et al.

Corporate Authors: Pfeifer H Bethge W Schönland S et al.

Source: Leukemia & lymphoma [Leuk Lymphoma] 2026 Aug 02, pp. 1-9. Date of Electronic Publication: 2026 Aug 02.

Publication Type: Journal Article

Journal Info: Publisher: Taylor & Francis Country of Publication: United States NLM ID: 9007422 Publication Model: Print-Electronic Cited Medium: Internet ISSN: 1029-2403 (Electronic) Linking ISSN: 10268022 NLM ISO Abbreviation: Leuk Lymphoma Subsets: MEDLINE

Intra-subtype heterogeneity shapes treatment response in KMT2A-rearranged ALL across all age groups.

Authors: Hartmann AM Bastian L Barz MJ et al.

Source: HemaSphere [Hemasphere] 2026 Feb 19; Vol. 10 (2), pp. e70324. Date of Electronic Publication: 2026 Feb 19 (Print Publication: 2026).

Publication Type: Journal Article

Journal Info: Publisher: Wiley Country of Publication: United States NLM ID: 101740619 Publication Model: eCollection Cited Medium: Internet ISSN: 2572-9241 (Electronic) Linking ISSN: 25729241 NLM ISO Abbreviation: Hemasphere Subsets: PubMed not MEDLINE

CD20 expression dynamics in adult B-cell acute lymphoblastic leukemia and impact on anti-CD20 treatment.

Authors: Szczepanowski M Richter J Bendig S et al.

Source: Journal of hematology & oncology [J Hematol Oncol] 2026 Jul 20; Vol. 19 (1). Date of Electronic Publication: 2026 Jul 20.

Publication Type: Journal Article

Journal Info: Publisher: Biomed Central Country of Publication: England NLM ID: 101468937 Publication Model: Electronic Cited Medium: Internet ISSN: 1756-8722 (Electronic) Linking ISSN: 17568722 NLM ISO Abbreviation: J Hematol Oncol Subsets: MEDLINE

Recurrent late-onset neutropenia after ofatumumab treatment in a case of multiple sclerosis.

Authors: Chen J Burmeister T Frankenstein L et al.

Source: Neurological research and practice [Neurol Res Pract] 2025 Mar 24; Vol. 7 (1), pp. 20. Date of Electronic Publication: 2025 Mar 24.

Publication Type: Letter

Journal Info: Publisher: BMC Country of Publication: England NLM ID: 101767802 Publication Model: Electronic Cited Medium: Internet ISSN: 2524-3489 (Electronic) Linking ISSN: 25243489 NLM ISO Abbreviation: Neurol Res Pract Subsets: PubMed not MEDLINE

Sustained HIV-1 remission after heterozygous CCR5Δ32 stem cell transplantation.

Authors: Gaebler C Kor S Allers K et al.

Source: Nature [Nature] 2026 Feb; Vol. 650 (8102), pp. 701-709. Date of Electronic Publication: 2025 Dec 01.

Publication Type: Journal Article; Case Reports; Research Support, N.I.H., Extramural

Journal Info: Publisher: Nature Publishing Group Country of Publication: England NLM ID: 0410462 Publication Model: Print-Electronic Cited Medium: Internet ISSN: 1476-4687 (Electronic) Linking ISSN: 00280836 NLM ISO Abbreviation: Nature Subsets: MEDLINE

Therapy-related AML: long-term outcome in a large cohort of AML-patients with intensive and non-intensive therapy.

Authors: Gross S Ihlow J Busack L et al.

Source: Blood cancer journal [Blood Cancer J] 2024 Sep 16; Vol. 14 (1), pp. 160. Date of Electronic Publication: 2024 Sep 16.

Publication Type: Journal Article; Research Support, Non-U.S. Gov't

Journal Info: Publisher: Nature Pub. Group Country of Publication: United States NLM ID: 101568469 Publication Model: Electronic Cited Medium: Internet ISSN: 2044-5385 (Electronic) Linking ISSN: 20445385 NLM ISO Abbreviation: Blood Cancer J Subsets: MEDLINE